Andreas Heinzel

Synthetic lethality guiding selection of drug combinations in ovarian cancer.

MicroRNAs in kidney transplantation.

A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.

Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.

Molecular disease presentation in diabetic nephropathy.

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.

Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.

Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes.

Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses.

Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft function.

Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.

Synthetic lethal combinations of low-toxicity drugs for breast cancer identified by genetic screens in yeast.

Steroid pretreatment of organ donors does not impact on early rejection and long-term kidney allograft survival: Results from a multicenter randomized, controlled trial.

Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.

The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population.

Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection.

Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.

Novel insights into non-HLA alloimmunity in kidney transplantation.

Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes.

Response to: "Biostatistics pitfalls: Lessons learned from analysis of medical data" by Yin et al.

Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury.

High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival.